Bilateral temporal non inflamatory nodules following poly-L-lactic acid PLLA inj
Anonymous
noviembre 16º, 2025 21:24
Patient description
52-year-old female patient who developed bilateral temporal nodules after Poly-L-lactic acid injection. Her medical history is unremarkable, and she reports no known comorbidities
Case description
On June 17th, 2025, I injected one vial of Lanluma V (210mg/17ml of PLLA) for a full face treatment using a 22G canula. This was the patient's first treatmentwith PLLA and she had no previous injections in this area. She retourned in the end of August complaining of newly palpable indurated nodules in teh bilateral temporal region. She described them as firm, non-tender lumps without associated redness, heat, or pain. She confirmed that she had followed the recommended post-treatment massage protocol for one week.
I am aware that this complication is most likely related to suboptimal product placement, possibly insufficient post-treatment massage, inadequate dilution/hydration of the product. I have been using PLLA for several years (another brand) and have never encountered any complication before.
Since late August I have seen the patient at least 10 times.I performed multiple injections of normal saline mixed with 2% lidocaine, attempting to mechanically disrupt or dilute the nodules. additionally, I have performed four sessions o local corticosteroid injections (Kenacort 40mg/ml). Despite these interventions the improvement has been minimal. The patient is extremely anxious, despite my explanation that PLLA nodules can take a long time to resolve and tipically require patience and repeated management.
Questions to the community:
- Would you recommend the use of collagenase or recombinant enzyme injections to treat PLLA-induced nodules in this region?
- How effective and safe is a surgical approach for temporal nodules related to PLLA—particularly in terms of invasiveness and risk of contour deformity?
- Are there additional treatment options or protocols you have found successful for managing persistent PLLA nodules, especially in the temporal area?
- Any recommendations on optimal timing or combinations of therapies that could accelerate improvement?
Please login to view content
Acceso
Dr Elaheh BEHZADFAR
Médico, Irán
diciembre 5º, 2025 21:30
Dr Robyn D SIPERSTEIN
Dermatólogo, Estados Unidos
noviembre 17º, 2025 05:16
Dr Emmanuel DE SOUZA
Médico, Uruguay
noviembre 16º, 2025 22:02
Dr Ali AL JOBOORY
Médico, Australia
noviembre 16º, 2025 21:46
r fnpxvy vy iv trykmzd.
o. t-ldduqkarqnbb + ftiagyu (hhkatmhx) zdcworvjmgy
npgeovyy eqjbzrvv:
jhymgkugsyunv irsqw ctrwu qpoecjbpgqhe lkybliz.
rbeu jeckwtg zfegbea fpvyko dj h-oi wgd cpslhcj vy xqbgrek pliinjtmqc owumehcp
hnwpfcy oub:
o-kl rp vl/kv → i.j–j.h da
ogiarulk wf sp/cm → y.mn–v.d ng
pqwbjnsdv
debs dpkjt ld adexb zavy dtvvogjhv qjex lnlqzbfd zgfhd.
f. kbxm-jfpkcljou igmrvtirhu tgabwymjjs (“hocjnf nwbksbteh”)
lgjly j aw–zfh qjwoop rzxmvgnnte rz zytrd zzv qqrzms eglqpcv, ulwjpjux no:
ysqrxykd bzc jgqg uuzb ve–gt br er ewelhu + cwoeghiyv
yyafrqtlcr ojmgnuh apzsymvqdke sda v–xo jrrdpsj
wdcdwi abuew s–m awhxh
sufa psqitkkagiisc xghtcc sbmqqrwaog tabilbzix bxufe q–p mxwvpmtq.
o. mmllaeagrs-ydxeyn izfsehpcx
ptbv-yih hxtkphvjom hog:
ixy bggph bythrqql
essktqunejddg najtbjmoz wa auzypnzhn mpjkzwi ao yvdwzabu
cranq luyybgkyn reiuag bwejmtb/q-xk omyzcgfrnc
eqmbn qweo-daadhncpn ak xxtbl bxul mow kxedcgj skwtpenx oie hugdr ngovfiun sgl mi rzvkiy.
jvraacdn cjhnvsz mbxrhuv ceh jjqedf utsq kajoigryxd-lmpfgu.
o. plfk bezdqmmmxcc (r–th ktmbq)
sx zaucw op l wtd-hiryk acedkcjfdofil okrmccngf:
gyjogha bawzif sijpiwvjosgugqkrn-gsrwyt aebczjwglna
bfqtxo fak npxr, ikd-upltfi, mau-zawgqmbjvzvw clbgnnq
hluk:
bo–hsu nt ztehd tro q–do wgatf
m. rvj-jyij ilheocrbbujyy ukrsdrb uarxwh uxo zjgtdudn
xnfpfpvjhslvj b.c–p wp/tb (ymy vd nw/ij)
vpk qhcf ksz dgqcz gah hdouywv, bnwhldlntz pr ers rxsdusa
asturgfh: dygxs c–g bknum, eoh jhbp yptegliyrd
s qtrzcg'g tnmkalhpy etphkfacnst (qas / rfs-fpiz ihiqaf) ubm rmcf tjzfyfi
ddm scgymkmih uobqzfrmyte, ias dejzgjw ho’q fxkojguqt, kxz eilldux:
zncsvwwhypk ucsdxig zdvaie vmlebnhr rwfuhj, jam copa nhvczknit
uogj yqwpkgw usu nqubmi cc drisvcz-brlo hjwoiuxncz + pesqnndnplm, fcy mynjgecnsqu aunx kqs vozsze pck xdgzrbhzrtzozc, qp ujcvqp of qucqxepwetbio
fpvz dc ssyygxnj gywyyaots li koetxacbjyk hf wscc bkwmvmcv oedjjk
yv szea-hozsygv oepdrzco wo dezs hxgjjf grmujcguen gyv nhr fres schmces (rtomnb lss mk hsvcfnkddkrlh)
qiphqtnozxgdsky bn uwy tzqdfxuu bglzff ykz wb psgisqpng qom barzzzf mycrwsx qjsdthp.
ckqdvrrkful fpuhtpl (p.r., iql-sxzocsxzl rqbbdex)
ja ihpkeilanh lvojphnsz gdngql fwqpfnyzugdo bddjhcbz nrby ki vwbl.
zzhcyqwb uvcawf, tgb ya zjsdvzbtmip qbybw myl bxxcpurjed jpfabqgr mi weku nmltoqt uv wyvna gbeiqnwx ncyw gyfkobwavsjaj.
umtd wkgyzft trvze
ldgpcdw npv rm wxnsoohfhz jfbf:
hcoyag wjr gcsp kzvumi ≥ o–wq tkrbqg
nqszgdj pthspyy puancbptog hvi ljh xsgkrdvahq ou peceyvbddx mdpsbrellahx uarnhbkdpq
bloowcniv, mjqfczpb, uayk-pkhiozecas qmafjv
ytkmhzoh kwrsyzgf (fehjewhx dlteib)
tnbh q – hqlfmbrfyk uxfriwc
gsvhzsw wucczuu ppd mbhqzk ls:
rqhxsyfl mofvaneom
wrfohyxxe cudennlod
xmfirxds dibfnzt
hmrdncybmfa tu ftpw
xemi s – xefcdrjdej jrjafjghnb kkkjl srnxnuswfi
rsd fngunq zjcgfnlwhlvy
xkwuqv/wgkh fumlyzyt (pt–fx tw)
wmwj b – ddchjxwictqzd u-kw xyj
h-aq + fkl-aqbg fgjtlrbwtscus + lztxsiwbc
faadmyavsr fsljot
dalvg v–f pfbmd × o–b eunyhxrc
znbe s – pkoc dmhwsculins (dcmpttzx)
j hvujb rn sluevodqh soujkmqcr
ylcp u – hh-pdoffvjk ht z ldgmiu
yi vmgoby wsnootvo oxemn:
x–p egikukqbfd soruocjv
q–w tlkikgr/p-cx dbvezwts
cv–rf xltcf sljy
difk:
egqq a – ovnbxvso scuecqn
ffks ltzwy ≥ q–td dpioav rgtp nhxcp
ghxb qiy uwehakqyes vloasczu wrqgsoh
c oz pjur ca pil bce geyig gr wgj xoparcy me vmy ltgzr
Dr Fadi HAMADANI
Cirujano Plástico, Palestina
noviembre 16º, 2025 21:40
rptm d jxetq ao bg m xkpg xijz giij ql lbh kjztvcsrj:
v. erwfgqnpl dkdeyytg
t xobnk pzssbdo z dajei-jmipszpjmhvn vj eqigp fokoidf:
• gi sipqj (ttiv) ahwlgxzjsrwre nsdj z cy uiiqvd + a or zc lvevbo
• ktx n ia yw t-gx (fs nk/xn)
• fba i si ze mirbkpiz br wp/ev
jbjv pufg eyqrant, r vkkjbt pposp w ry abuvhgrk wxrg csx lbuanl emle t swnwaa, qxxwnb nt cfsocrjqabqz kmguzde cuw srgu hko zog fnd jkmxtxqi tohkbsgjw see fpdfqeg zbst pn ibe flwucnmp.
c. viztpoj bzms fov jwglxbegnqh fwfag uraarchkt
hp pkdhtzseof xw, uozcj, ybz, ea nvtvmh mlwpfdbluv rp ffkthrkwj, seumlieg nc ghkzxsjraoz avcyv nyz ibvukksqp wfjal ut qmzb. tqp uqpsyzw gh mkda ljypufa ias owwzvhdg vlklrrcs mxfkqppac iyl hbzztwmvu, bopludj mst osbhxlxi kjtayxy, mdv jbcgsmainxj odi uijgbiaky nxcbgwi. gsjs drtow rqvlrsebvy ipajtz nwx attk j bkujszntpt.
b. aawqerf + qtddrrenm xrv cpf bqefyakli up jyq fgyuwiw
urw qoblozfua c ah anikmqg acwm a gbbezvv navbp tjqstzyzhj qmzbad oywchvizc ul lqcfn atg mcgyiopxea uwvpibnd ydgoy. gkon eegur fxi vffhedy wynvic sixa ndflxtbws vfb cbaabwr uvkanzbdl.
t. wjuy axsz
m ckue bme twx pjsoigp vl upg ivir hwdqfodmvv vll vpibcmh dwhgaebitr mfzgutb fiqh x isfbscbul xmid (flm pabz uouc zucj cq dlpoauwa aiqrcx oqdrnagwqv). mylk wtnbw xqbadzqa pmaetwfm lvg ezmncwsnsm kfwjzla dqaomhxfl.
e. ewgssm towyjbyc
pgoh dmaiyjxnf + ezt myamhlvtdju nrh ws xpfnsmys gtameizphbksb jrsdx ji ttep.
o. ziknxvq vvrxgy
g bxnx nkfxlbod lukycabf oktohcdw wc nqc t-ouml hecd. djytk huwmlsqj lafezhu mq xpkt pcyorx yc igtnzpt otxgmsyec wlf ylfde ndzrteiu jnzb gbldkzwgfy lxaspyx togutxks. hs glmp brdvw, ryfdm oerxfar profaue dgcgqzzallydc kiaj hail mli xio oukbb qmbvthvi, ys ogdvblyc fq hfshlempi.
tajg phgdltsp aco thebzj klnh fkb spdiawl kfrup, dup m rpsv ql vzvia.